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SBackground: Preoperative pulmonary function tests are used to assess operability for either lobectomy or pneu-
monectomy. Current guidelines for defining high-risk patients for anatomic lung resection on the basis of these
tests were developed in the era of open thoracotomy. We studied the outcomes of such high-risk patients after
video-assisted thoracoscopic surgical resections to assess the performance of these guidelines.
Methods: Records of all patients who underwent anatomic resection from 2001 to 2009 at a single institution
were queried for pulmonary function and perioperative outcomes. Patients with predicted postoperative forced
expiratory volume in 1 second or predicted postoperative lung carbon dioxide diffusing capacity less than 40%
were considered to have limited pulmonary reserve. Perioperative outcomes of patients with limited pulmonary
reserve who underwent thoracoscopic resection were documented and compared with those of similar patients
who underwent open resection.
Results: Of 600 patients assessed, 70 had limited pulmonary reserve according to our criteria. Forty-seven of
them underwent thoracoscopic resection. This cohort had excellent outcomes, with mortality of 2.1%, pneumo-
nia rate of 4.3%, and discharge independence rate of 95.7%. Relative to contemporary patients undergoing open
resection (N ¼ 23, including 12 conversions), patients undergoing thoracoscopic resection had lower incidence
of pneumonia (4.3% vs. 21.7%, P<.05) and shorter intensive care unit stay (2 vs 4 days, P ¼ .05).
Conclusions: Patients with marginal lung function tolerate thoracoscopic anatomic resection well. Reassess-
ment of the traditional pulmonary function test guidelines for operability is warranted in the current era of thor-
acoscopic lung surgery. (J Thorac Cardiovasc Surg 2011;141:459-62)Current pulmonary function guidelines for patient selection
for lung resectionwere developed in an era of open thoracot-
omy. Patients previously considered not to be candidates for
operation because of poor lung function, however, may be
able to tolerate resection with minimally invasive surgery
and improved postoperative care. Although some data exist
regarding the benefits of thoracoscopic sublobar resection in
patients with borderline lung function,1-3 few outcome data
are available regarding thoracoscopic lobectomy in this
fragile population. We reviewed the morbidity and
mortality of patients with limited pulmonary reserve
undergoing video-assisted thoracoscopic surgery (VATS)
for anatomic lung resection. Secondarily, we compared their
outcomes with those of a contemporary cohort of patients
undergoing anatomic lung resection by thoracotomy.
MATERIALS AND METHODS
A retrospective review of patients who underwent lobectomy or
pneumonectomy during the years 2000 to 2009 at Roswell Park Cancere Department of Surgery,a State University of New York; and the Department
oracic Surgery,b Roswell Park Cancer Institute, Buffalo, NY.
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The Journal of Thoracic and CaInstitute, Buffalo, NY, was performed to select patients with predicted
postoperative forced expiratory volume in 1 second (FEV1) less than
40% or a predicted postoperative diffusing capacity of the lung for car-
bon monoxide (DLCO) less than 40%. Data were obtained from patients’
medical charts and electronic medical records with institutional review
board approval. Data recorded were age, sex, smoking history, current
smoking status, preoperative FEV1, preoperative DLCO, pathologic stage,
complications, and 30-day mortality. The individual predicted postopera-
tive FEV1 and predicted postoperative DLCO values were calculated by
multiplying the preoperative FEV1 or DLCO by the number of lung seg-
ments being removed and then subtracting the calculated amount from
the preoperative FEV1 or DLCO. Adjustments were made with lung perfu-
sion scan data where appropriate. Cardiopulmonary exercise testing was
performed in 26 cases. The value of maximum oxygen consumption
was available in 23 cases. Perioperative data also tabulated included the
incidences of pneumonia, myocardial infarction, atrial fibrillation, adult
respiratory distress syndrome, prolonged air leak, intubation, and dis-
charge with chest tube or oxygen therapy; mean total hospital stay;
mean intensive care unit stay; and whether the patient was discharged
to his or her home or to a rehabilitation facility. Morbidities such as pneu-
monia and myocardial infarction were counted if they were noted in daily
progress notes and supported by radiologic, laboratory, or other diagnos-
tic tests (eg, electrocardiography). Continuous and categoric variables
were compared across groups with the Student t test and the Fisher’s
Exact test, respectively.RESULTS
Of 600 patients from 2001 through 2009 who underwent
anatomic resection including lobectomy or pneumonectomy,
70 patients had limited pulmonary reserve according to our
criteria. During this same period, 72 patients underwentrdiovascular Surgery c Volume 141, Number 2 459
TABLE 1. Patient characteristics
Characteristics
VATS
(n ¼ 47)
Open
(n ¼ 23) P value
Age (y, mean) 69.2 59.2 .003125
Sex (male/female) 16/31 11/12
ASA 2.7 2.5 .265
Preoperative FEV1
(%, mean  SD)
58.5%  21% 57.8%  14% .883
Preoperative DLCO
(%, mean  SD)
44%  10% 48.0%  13% .219
Predicted postoperative FEV1
(%, mean  SD)
46.1%  17% 41.7%  11% .201
Predicted postoperative DLCO
(%, mean  SD)
34.8%  8% 34.8%  11% .985
Smoking status (no.)
Current smoker 8 (17.0%) 4 (17.4%) >.999
Nonsmoker or
previous smoker
34 (72.3%) 12 (52.2%)
Unknown 5 (10.6%) 7 (30.4%)
TNM stage (no.)
T1 17 (36.2%) 7 (30.4%) .780
T2 22 (46.8%) 9 (39.1%) .614
T3 0 (0%) 2 (8.7%) .105
T4 1 (2.1%) 2 (8.7%) .250
N0 32 (68.1%) 8 (34.9%) .127
N1 6 (12.8%) 8 (34.9%) .051
N2 2 (4.3%) 0 (0%) >.999
N3 0 (0%) 0 (0%) >.999
M1 1 (2.1%) 0 (0%) >.999
Clinical stage (no.)
IA 14 (29.8%) 6 (26.1%) >.999
IB 17 (36.2%) 4 (17.4%) .165
IIA 2 (4.3%) 1 (4.3%) >.999
IIB 3 (6.4%) 6 (26.1%) .051
IIIA 2 (4.3%) 1 (4.3%) >.999
IIIB 1 (2.1%) 2 (8.7%) .250
IV 1 (2.1%) 0 (0%) >.999
Resection type (no.)
Lobectomy 45 (95.7%) 16 (69.6%) .004
Right upper lobe 14 (29.9%) 2 (8.7%) .069
Right middle lobe 3 (6.4%) 2 (8.7%) >.999
Right lower lobe 8 (17.0%) 3 (13.0%) >.999
Left upper lobe 12 (25.5%) 5 (21.7%) >.999
Left lower lobe 8 (17.0%) 4 (17.4%) >.999
Bilobectomy (no.) 1 (2.1%) 1 (4.3%) >.999
Right upper lobe and
right middle lobe
1 (2.1%) 1 (4.3%) >.999
Pneumonectomy (no.) 1 (2.1%) 6 (26.1%) .004
Right lung 1 (2.1%) 2 (8.7%) .250
Left lung 0 (0%) 4 (17.4%) .010
VATS, Video-assisted thoracoscopic surgical group; ASA, American Society of Anes-
thesiologists physical status classification; FEV1, forced expiratory volume in 1 sec-
ond; DLCO, diffusing capacity of lung for carbon monoxide.
Abbreviations and Acronyms
DLCO ¼ diffusing capacity of the lung for carbon
monoxide
FEV1 ¼ forced expiratory volume in 1 second
VATS ¼ video-assisted thoracoscopic surgery
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Swedge resections for lung cancer but are not included in this
analysis. Of these 70 patients, 47 patients (66.2%) had a re-
section completed thoracoscopically. The 23 patients with
open resections included 12 patients with VATS procedures
thatwere converted to thoracotomy for the following reasons:
pulmonary arterial bleeding (2 patients), adhesions (2 pa-
tients), planned conversion (1 patient), and tumor anatomy
(eg, sleeve resection required, 7 patients). Table 1 summa-
rizes the patient characteristics in both the VATS and open
groups. Patients in the VATS group were older. There were
no differences between the 2 surgical groups in predicted
postoperative FEV1 or in predicted postoperative DLCO.
There was a significant difference between the number of
pneumonectomies in the VATS group (n ¼ 1) and that in
the open group (n ¼ 6, P ¼ .004). In the analysis of patient
groups determinedby the intraoperative procedure performed
(actual surgery analysis), 10 patients in the VATS group and 7
patients in the open group had both a predicted postoperative
FEV1 and a predicted postoperative DLCO less than 40%. In
the intent-to-treat analysis, 13 patients in the VATS group
and 4 patients in the open group had both a predicted postop-
erative FEV1 and a predicted postoperative DLCO less than
40%. Perioperative variables analyzed for the actual surgery
received and the intent-to-treat groups are shown in Tables 2
and 3, respectively.
One patient in the VATS group died in the perioperative
period of large bowel ischemia, liver infarction, and sep-
sis. One patient in the open group died of congestive heart
failure. In the actual surgery analysis, the VATS group had
a decreased rate of pneumonia (4.3% vs 21.7%,
P ¼ .035), shorter intensive care unit stay (2 days vs 4
days, P ¼ .05), and a trend toward shorter overall hospital
stay (7 days vs 10 days, P ¼ .058) relative to the open
group. In the VATS group both patients who acquired
pneumonia had undergone a lobectomy, and in the open
group 4 of the total 5 patients with pneumonia had under-
gone a lobectomy rather than a pneumonectomy. Adult
respiratory distress syndrome occurred in more patients
in the open group when the intent-to-treat analysis was
performed (0% vs 18.2%, P ¼ .023). At discharge, only
4.3% or 6.8% of the patients who had undergone VATS
were transferred to a rehabilitation facility, versus
17.4% or 18.2% of those with open thoracotomy, accord-
ing to the actual surgery and intent-to-treat analyses,
respectively.460 The Journal of Thoracic and Cardiovascular SurgDISCUSSION
Anatomic surgical resection offers the best chance of
cure for patients with resectable lung cancer. Thoracoscopic
resections are associated with lower morbidity than areery c February 2011
TABLE 2. Comparison between video-assisted thoracoscopic surgical
and open groups: Actual surgery analysis
VATS
(n ¼ 47)
Open
(n ¼ 23)
P
value
Pneumonia (no.) 2 (4.3%) 5 (21.7%) .035
Myocardial infarction (no.) 0 (0%) 2 (8.7%) .105
Atrial fibrillation (no.) 7 (14.9%) 0 (0%) .087
Adult respiratory distress
syndrome (no.)
0 (0%) 2 (8.7%) .105
Intubation>24 h (no.) 2 (4.3%) 2 (8.7%) .593
Discharge with chest tube (no.) 4 (8.5%) 0 (0%) .295
Prolonged air leak (>5 d, no.) 6 (12.8%) 4 (17.4%) .72
Oxygen at discharge (no.) 20 (42.6%) 10 (43.5%) >.999
Oxygen at>4 wk (no.) 6 (12.9%) 5 (21.7%) .49
Mean total stay (d) 7 10 .058
Mean intensive care unit stay (d) 2 4 .05
Rehabilitation (no.) 2 (4.3%) 4 (17.4%) .09
Mortality (no.) 1 (2.1%) 1 (4.3%) >.999
VATS, Video-assisted thoracoscopic surgical group.
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high-risk patients, a group including patients with limited
pulmonary reserve. For these patients, the decision to per-
form the oncologically optimal lobectomy or pneumonec-
tomy rather than a wedge resection or a segmentectomy
must be weighed against the mortality and morbidity asso-
ciated with the larger resection. Selection criteria for these
patients typically include a combination of standard pulmo-
nary function testing with perfusion scans and pulmonary
exercise testing.4 These tests, although imperfect,5 remain
the most objective criteria available. The decision-making
algorithm for selection for surgery is uniform across all sur-
geons at our institution. Although the decision to offer sur-
gery depends on the overall functional status of the patientTABLE 3. Comparison between video-assisted thoracoscopic surgical
and open groups: Intent-to-treat analysis
VATS
(n ¼ 59)
Open
(n ¼ 11)
P
value
Pneumonia (no.) 5 (8.5%) 2 (18.2%) .302
Myocardial infarction (no.) 1 (1.7%) 1 (9.1%) .292
Atrial fibrillation (no.) 7 (11.9%) 0 (0%) .587
Adult respiratory distress
syndrome (%)
0 (0%) 2 (18.2%) .023
Intubation>24 h (no.) 4 (6.8%) 0 (0%) >.999
Discharge with chest tube (no.) 4 (6.8%) 0 (0%) >.999
Prolonged air leak (>5 d, no.) 9 (15.3%) 1 (9.1%) >.999
Oxygen at discharge (no.) 27 (45.8%) 3 (27.3%) .331
Oxygen at>4 wk (no.) 9 (15.3%) 2 (18.2%) >.999
Mean total stay (d) 7 12 .10
Mean intensive care unit stay (d) 2 4 .17
Home with or without home
health care (no.)
54 (91.5%) 8 (72.7%) .242
Rehabilitation (no.) 4 (6.8%) 2 (18.2%) .242
Mortality (no.) 1 (1.7%) 1 (9.1%) >.999
VATS, Video-assisted thoracoscopic surgical group.
The Journal of Thoracic and Cacoupled with objective pulmonary function tests, data from
perfusion scans and cardiopulmonary exercise tests are in-
cluded in the decision-making process. In general, we use
a guideline of maximum oxygen consumption less than
10 mL/(kg $ min) to exclude a surgical anatomic resection.
The primary focus of our analysis was the assessment of
outcome of VATS resections in this high-risk population.
The comparison with a contemporary group undergoing
open resection was secondary and performed with the under-
standing that this comparison is statistically challenged by
the small numbers in the open group. An audit of our perio-
perative data presented here demonstrates that thoracoscopic
lobectomy is safe for patientswith limited pulmonary reserve
and may provide an advantage relative to open lobectomy.
Themorbidity andmortality associatedwithVATSresections
presented here compare favorably with outcomes of ana-
tomic surgical resections in patients considered to be at nor-
mal risk. The incidence of pneumonia among patients
undergoing VATS lung resection in our series is comparable
to incidences reported by Paul and colleagues6 and Villama-
zar and associates.7 The incidence of pneumonia among pa-
tients who underwent open lung resection in our series is
comparable to incidences in other series of patients with
less compromised lung function.8-10 The higher rate of
pneumonia is not unexpected among patients with
compromised pulmonary function after lung resection by
thoracotomy. The etiology is likely multifactorial and
related to the increased pain, the abnormality of chest wall
mechanics, and the decreased ability to cough, breathe
deeply, and ambulate after thoracotomy, all of which
contribute to an increased risk for pneumonia. Although
significantly more patients in our open group underwent
pneumonectomy, only 1 of the 5 patients in the open group
who acquired pneumonia had undergone pneumonectomy;
the other 4 had undergone lobectomy. The higher incidence
of pneumonia in the open group thus cannot be ascribed to
the higher number of pneumonectomies in that group.
Rates of atrial fibrillation, renal failure, and prolonged air
leak, duration of chest tube, hospital stay, and mortality are
comparable to values in other series of patients with less
compromised pulmonary function.
In our series, although patients who underwent VATS
lung resection were older, they had a lower incidence of
postoperative pneumonia than did patients who underwent
thoracotomy. The decreased incidence of pneumonia
among these patients likely contributed to their shorter in-
tensive care unit and overall stays and to their decreased
need for transfer to a rehabilitation facility. These favorable
outcomes support careful consideration of VATS lobectomy
for patients with predicted postoperative FEV1 and pre-
dicted postoperative DLCO of 40% or less. We recognize
that a small number of patients who have unanticipated
conversion to thoracotomy may end up with chronic debil-
itating respiratory status. This is reflected by the decrease inrdiovascular Surgery c Volume 141, Number 2 461
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analysis. We recommend that such challenging cases not be
undertaken by the surgeon negotiating his or her learning
curve with thoracoscopic resections. In experienced hands,
however, thoracoscopic resections for such high-risk pa-
tients may provide outcomes equivalent to open resections
in patients considered to be at normal risk.
We recognize that any conclusions and analyses based on
our data are limited by the small numbers and retrospective
nature of our study. In light of our limited numbers, a statis-
tically relevant comparison of the patients with conversion
to those undergoing planned open surgery cannot be made.
These issues, however, deserve further scrutiny with larger
surgical databases.References
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